Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

NCT01149707

Conditions
Colitis, Colonic Diseases, Digestive System Diseases, +19 more
Locations
  • PurGenesis Investigational Site Jena, Germany
  • PurGenesis Investigational Site Köln-Merheim, Germany
  • PurGenesis Investigational Site Ludwigshafen, Germany
  • PurGenesis Investigational Site Minden, Germany
View Trial Details
Completed

A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)

NCT01414855

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • cCare Encinitas, California, United States
  • University of Colorado Cancer Center Department of Hematology Aurora, Colorado, United States
  • Rocky Mountain Cancer Ctr - Denver (Williams) Denver, Colorado, United States
View all 38 locations
View Trial Details
Completed

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +23 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Safety Study of SGN-CD70A in Cancer Patients

NCT02216890

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +28 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cardinal Bernardin Cancer Center / Loyola University Medical Center Maywood, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 17 locations
View Trial Details
Completed

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

NCT01729806

Conditions
CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details

Related conditions